2020 ASM Program

ASM ONLINE PROGRAM
30th November – 2nd December

Monday, 30th November 2020
SPEED NETWORKING ICEBREAKER 0930-1000 Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Delegates will be randomly allocated through a progression of four-person video group chats. You never know who you might meet!
PLENARY #1 WELCOME & ORIENTATION 1000-1015 Chair: Neil Boudville, President, ANZSN
POLYCYSTIC KIDNEY DISEASE: FROM BEDSIDE TO BENCH TO CLINICAL HORIZON 1015-1115 Dr Lisa Guay-Woodford McGehee Joyce Professor of Pediatrics at the Children’s National Medical Center (CNMC), Washington DC

1115-1130 REFRESHMENT BREAK
Stretch, stand up, get ready for the breakout sessions…which will you attend?

CONCURRENT SESSIONS
1130-1300
The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

MODELLING KIDNEY DISEASES SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 x presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Tim Hewitson
Moderator: Zoe McArdle

Melissa Little, Murdoch Children’s Research Institute

Aude Dorison, Murdoch Children’s Research Institute

Tom Forbes, Royal Children’s Hospital

Ian Smyth, Monash University

#1: REBUILDING A KIDNEY: HOW FAR ARE WE FROM TREATMENT

#2: CONGENITAL NEPHROTIC SYNDROME: WHAT CAN WE LEARN FROM KIDNEY ORGANOIDS?

#3: MODELLING GENETIC TUBULAR KIDNEY DISEASE WITH KIDNEY ORGANOIDS REGENERATED FROM PATIENT INDUCED PLURIPOTENT STEM CELLS

#4: A MUTATION AFFECTING LAMININ ALPHA 5 POLYMERISATION GIVES RISE TO A SYNDROMIC DEVELOPMENTAL DISORDER

Close Session Details

CHRONIC KIDNEY DISEASE (CKD) SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Irene Ruderman

Matthew Roberts, Deputy Director of Nephrology, Eastern Health

Brendon Neuen, NHMRC Postgraduate Scholar at The George Institute, Australia

Eric Tan, Research Fellow/NHMRC Early Career Research Fellow, Swinburne University of Technology, Australia

#1: CARDIOVASCULAR BIOMARKERS AND MECHANISMS OF DISEASE – WHERE ARE WE NOW?

#2: SGLT2 INHIBITION IN CKD: CLINICAL IMPACT

#3: CHARACTERISING NEUROCOGNITIVE IMPAIRMENTS ACROSS THE STAGES OF CHRONIC KIDNEY DISEASE

Close Session Details

PAEDIATRIC SYMPOSIUM – TRANSITION TO ADULT CARE

View Session Details

This 90 minute session will consist of 4 x 15-minute presentations followed by a 30-minute live Q&A where speakers will answer questions submitted by the audience.

Chair: Anna Francis
Moderator: Rowena Lalji

Chanel Prestidge, Starship Children’s Hospital

Rob Carroll, American Society Of Immunogenetics and Histocompatibility

Shilpa Jesudason, Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service

Luke Macauley, University of Adelaide

#1: PAEDIATRIC PERSPECTIVE

#2: ADULT PERSPECTIVE

#3: KHA (KIDNEY HEALTH AUSTRALIA) AND THE CONSUMER PERSPECTIVES

#4: KHA (KIDNEY HEALTH AUSTRALIA) AND THE CONSUMER PERSPECTIVES

Close Session Details

PRECISION DOSING: OPTIMIZING CRITICAL DOSE DRUGS IN DIALYSIS & TRANSPLANTATION SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 22-minute presentations followed by a 20-minute live Q&A where speakers will answer questions submitted by the audience.

Chair: Gopi Rangan
Moderator: Melanie Wyld

Katherine Barraclough, Nephrologist, Royal Melbourne Hospital.

David Metz, Paediatric Nephrologist & Clinical Pharmacologist, Royal Children’s Hospital Melbourne.

Darren Roberts, Nephrologist & Clinical Pharmacologist, St Vincent’s Hospital Sydney.

#1: DOSING OF MYCOPHENOLATE AND TACROLIMUS IN KIDNEY TRANSPLANTATION: WHAT IS THE EVIDENCE?

#2: OVERCOMING THE BARRIERS TO MYCOPHENOLATE DOSE INDIVIDUALISATION

#3: DOSE-ADJUSTMENT DURING HAEMODIALYSIS OR APHERESIS TO OPTIMISE PATIENT OUTCOMES

Close Session Details

1300-1355 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall

PLENARY #2
1355-1605
Chair: Neil Boudville
Young Investigator Award Session
12 minute live presentations followed by questions from the audience.

BASIC SCIENCE

LATENT CYTOMEGALOVIRUS INFECTION ENHANCES ANTI-MYELOPEROXIDASE AUTOIMMUNITY AND GLOMERULONEPHRITIS IN MICE
Juli Jaw

THE EFFECTS OF GESTATIONAL HYDRALAZINE ON OBESITY-RELATED CHRONIC KIDNEY DISEASE IN OFFSPRING
Benjamin P. Larkin

NECROPTOSIS IN RENAL ISCHAEMIA REPERFUSION INJURY
Aspasia Pefanis

HEAT TREATED DIET INTAKE DRIVES INTESTINAL PERMEABILITY, COMPLEMENT ACTIVATION AND ALBUMINURIA IN RODENTS
Matthew Snelson

CLINICAL SCIENCE

DIETARY POTASSIUM INTAKE AND ALL-CAUSE MORTALITY IN ADULTS UNDERGOING HEMODIALYSIS: THE DIET-HD COHORT STUDY
Amélie Bernier-Jean

COMPARISON BETWEEN FREEHAND AND NEEDLE GUIDE TECHNIQUES FOR TEACHING PERCUTANEOUS RENAL BIOPSY: A RANDOMISED CONTROLLED TRIAL
Elizabeth Downie

EVALUATING THE FEASIBILITY OF A MOBILE PHONE TEXT MESSAGING INTERVENTION ON IMPROVING DIETARY BEHAVIOURS IN PATIENTS RECEIVING HAEMODIALYSIS (KIDNEYTEXT)
Jessica Dawson

THE FILTRATION IN THE NEUROPATHY OF END-STAGE KIDNEY DISEASE (FINESSE) RANDOMISED CONTROLLED TRIAL
Amy Kang

1605 -1615 REFRESHMENT BREAK
Stretch, stand up, make a contact in the Meeting Hub, browse the Exhibition or the Posters. Get ready for the breakout sessions…which will you attend?

CONCURRENT SESSIONS
1615-1745
The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

KIDNEY HEALTH AUSTRALIA (KHA) CLINICAL SCIENCE AWARD SESSION

View Session Details

This 90 minute session will comprises of 6 live 12 minute presentations followed by questions.

Chair: Angela Webster
Moderator: Rathika Krishnasamy

SEX DIFFERENCES IN MORTALITY AMONG PEOPLE WITH END-STAGE KIDNEY DISEASE: DO WOMEN ALWAYS LIVE LONGER?
Nicole De La Mata

A STATE-WIDE APPROACH TO IDENTIFY CHRONIC KIDNEY DISEASE, ASSOCIATED RISK FACTORS AND OUTCOMES IN THE COMMUNITY USING LINKED DATASETS (CKD.TASLINK)
Matthew Jose

THE RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS AND ACADEMIC PERFORMANCE IN CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE
Rabia Khalid

SUCCESSFUL IMPLEMENTATION OF INCREASED VIRAL RISK DONOR WAITING LIST FOR PRE-CONSENTED WAITLISTED RECIPIENTS IN VICTORIA
Darren Lee

ASSOCIATIONS BETWEEN PULSE WAVE VELOCITY, AORTIC CALCIFICATION AND CARDIAC STRUCTURE AND FUNCTION
Nicole Lioufas

EXCESS DEATHS AND LIFE YEARS LOST IN CHILDREN WITH END-STAGE KIDNEY DISEASE IN AUSTRALIA AND NEW ZEALAND
Melanie Wyld

Close Session Details

BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 22-minute presentations followed by a 20-minute live Q&A where speakers will answer questions submitted by the audience.

Chair: David Nikolic-Paterson
Moderator: Juli Jaw

Raelene Pickering, Post-Doctoral Researcher, Department of Diabetes, Monash University

Rob Walker, Department of Medicine, Otago Medical School University; Head of Nephrology, Southern District Health Board; Director of ‘the Kidney in Health and Disease research theme”, University of Otago

Kate Denton, Monash University

#1: TRANSACTIVATION OF RAGE MEDIATED ANGIOTENISIN-INDUCED INFLAMANTION AND ATHEROGENESIS

#2: LITHIUM, GSK3 AND RENAL CELL FUNCTION

#3: THE ROLE OF THE KIDNEY IN THE CONTROL OF ARTERIAL PRESSURE

Close Session Details

MINI ORALS #1 | GENERAL NEPHROLOGY

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Carolyn Clark
Moderator: Hilton Gock

SHOULD WE TREAT AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE WITH AMLODIPINE?
Sean Barton

CHANGES IN PLASMA METABOLITES IN INDIVIDUALS WITH DIABETES ASSOCIATED CHRONIC KIDNEY DISEASE: A CLOSER LOOK AT LIPID PROFILES AND CARDIOVASCULAR RISK
Ashani Lecamwasam

GUT MICROBIOME COMPOSITION REMAINS STABLE IN INDIVIDUALS WITH DIABETES-RELATED EARLY TO LATE STAGE CHRONIC KIDNEY DISEASE
Ashani Lecamwasam

DNA METHYLATION PROFILING IDENTIFIES EPIGENETIC DIFFERENCES BETWEEN EARLY VERSUS LATE STAGES OF DIABETIC CHRONIC KIDNEY DISEASE
Ashani Lecamwasam

ESTABLISHING RECOMMENDED STANDARDS FOR INFORMED CONSENT FOR MAINTENANCE DIALYSIS
Peter Mount

RENAL SUPPORTIVE CARE AT PRINCE OF WALES HOSPITAL: 5-YEAR EXPERIENCE
Lin Lin Myat

LIVE Q&A

BIOMARKERS THAT PREDICT PROGRESSION OF CHRONIC KIDNEY DISEASE MORE ACCURATELY THAN ESTABLISHED CLINICAL PARAMETERS
Evan Owens

KIDNEY FUNCTION AFTER INITIATION AND DISCONTINUATION OF EMPAGLIFLOZIN IN HEART FAILURE PATIENTS WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE EMPERIAL TRIALS
Andrew Sindone

STORIES AND JOURNEYS: UNDERSTANDING THE EXPERIENCE OF LIVING WITH KIDNEY DISEASE AND RECEIVING HAEMODIALYSIS THROUGH STORYTELLING
Leigh Tesch

EFFECT OF LANTHANUM CARBONATE ON ENDOGENOUS CALCIPROTEIN PARTICLES IN CKD PATIENTS – RESULTS FROM A PLACEBO-CONTROLLED RANDOMISED TRIAL
Mark Tiong

MIDKINE EXPRESSION IN KIDNEY BIOPSIES OF PATIENTS WITH ACUTE AND CHRONIC KIDNEY DISEASE
Jeffrey Wang

LIVE Q&A

Close Session Details

MINI ORALS #2 | EXPERIMENTAL TUBOLOINTERSTITIAL DISEASE / HAEMODIALYSIS

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Amelia Fotheringham
Moderator: Sanela Redzepagic

TGF-BETA1 IS A REGULATOR OF THE PYRUVATE DEHYDROGENASE COMPLEX IN PRIMED RENAL FIBROBLASTS
Tim Hewitson

KCA3.1 REGULATES MITOPHAGY IN DIABETIC KIDNEY DISEASE
Chunling Huang

FOLLISTATIN TREATMENT IN FOLIC ACID INDUCED RENAL FIBROSIS
Min Yen Lee

A NOVEL AND UNIQUE FC-FUSION PROTEIN I-BODY AD-214 AMELIORATED KIDNEY FIBROSIS IN VITRO AND IN MICE WITH UNILATERAL URETERAL OBSTRUCTION
Qinghua Cao

PHARMACOLOGICAL INHIBITION OF APOPTOSIS SIGNAL-REGULATED KINASE-1 REDUCES STRESS-INDUCED CELLULAR SENESCENCE IN DIABETIC KIDNEYS
Greg Tesch

JNK INHIBITION PREVENTS ACUTE ARISTOLOCHIC ACID-INDUCED KIDNEY INJURY
Fan Yang

LIVE Q&A (EXPERIMENTAL TUBOLOINTERSTITIAL DISEASE)

A CLINICAL AUDIT OF THE IMPACT OF HEPARIN LOCKING SOLUTION CONCENTRATION ON CATHETER DYSFUNCTION
Anna Krelle

TEMPORAL TREND IN THE PATTERN, ORGANISM TYPE AND CLINICAL OUTCOMES OF CATHETER-RELATED BLOOD STREAM INFECTION IN HAEMODIALYSIS PATIENTS IN WESTERN AUSTRALIA
Jessica Phillips

BONE MICROARCHITECTURE IN PATIENTS UNDERGOING PARATHYROIDECTOMY FOR MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM
Irene Ruderman

VASCULAR CALCIFICATION IN SKIN AND SUBCUTANEOUS TISSUE IN PATIENTS WITH CHRONIC AND END-STAGE KIDNEY DISEASE
Irene Ruderman

LIVE Q&A (HEAMODIALYSIS)

Close Session Details

MINI ORALS #3 | EPIDEMIOLOGY & PUBLIC HEALTH

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Moderator: Georgina Irish

EFFECT OF SEVERE CYCLONE ON INCIDENCE AND CLINICAL PHENOTYPE OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) ASSOCIATED RENAL VASCULITIS (AAV) IN CENTRAL QUEENSLAND OF AUSTRALIA
Justin Chan

RISING INCIDENT RATES AND POORER ACCESS TO KIDNEY TRANSPLANTATION AMONG ABORIGINAL CHILDREN AND YOUNG ADULTS IN AUSTRALIA
Swasti Chaturvedi

TEMPORAL CHANGES AND RISK FACTORS ASSOCIATED WITH EARLY MORTALITY ATTRIBUTED TO DIALYSIS WITHDRAWAL IN PATIENTS WITH KIDNEY FAILURE
Jenny Chen

TRENDS IN JOINT REPLACEMENT FOR AUSTRALIAN DIALYSIS AND TRANSPLANT PATIENTS: A DATA LINKAGE STUDY
Christopher Davies

DIALYSIS AND DRIVING: AN ANONYMOUS SURVEY OF PATIENTS RECEIVING DIALYSIS FOR END STAGE KIDNEY DISEASE
Alison Graver

A SMARTPHONE-APP INTERVENTION TO BUILD HEALTH LITERACY SKILLS IN PEOPLE LIVING WITH KIDNEY FAILURE REQUIRING HAEMODIALYSIS – A FEASIBILTY STUDY
Jennifer Isautier

LIVE Q&A

VARIABILITY IN eGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE
Min Jun

BODY MASS INDEX TRAJECTORIES FROM CHILDHOOD TO MIDLIFE ARE ASSOCIATED WITH SUBCLINICAL KIDNEY DAMAGE IN MIDLIFE
Conghui Liu

CHILDHOOD CARDIORESPIRATORY FITNESS AND EARLY MARKERS OF KIDNEY DISEASE IN MIDDLE AGE: A POPULATION-BASED COHORT STUDY
Conghui Liu

COMBINED CHANGES IN GLOMERULAR FILTRATION RATE AND ALBUMINURIA AND RISK OF KIDNEY DISEASE PROGRESSION IN ROUTINE CLINICAL PRACTICE
Brendon Neuen

AN OVERVIEW OF PATIENT CHARACTERISTICS AND OUTCOMES IN THE CKD.QLD REGISTRY, AUSTRALIA, 2011 to 2018
Zaimin Wang

STATEWIDE LONGITUDINAL ANALYSIS TO PREDICT FUTURE DIALYSIS DEMAND IN WA: PROOF OF CONCEPT STUDY
Henry Moody

LIVE Q&A

Close Session Details

DAY ONE CONCLUDES
The Networking Hub remains open for scheduled meetings with sponsors and other attendees. Schedule a meeting through the Networking Hub.

TUESDAY

Tuesday, 1st December 2020
SPEED NETWORKING ICEBREAKER 0930-0955 Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Delegates will be randomly allocated through a progression of four-person video group chats. You never know who you might meet!
WELCOME 0955-1000
PLENARY #3 CVD INTERVENTIONS IN CKD AND DIALYSIS – WHAT (MIGHT) WORK 1000-1100 Chair: Natasha Rogers Professor Patrick (Paddy) Mark Professor of Nephrology and Honorary Consultant Nephrologist at the Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Hospital Glasgow

1100-1105
5 min changeover break

CONCURRENT SESSIONS
1105-1235

The following sessions run concurrently and attendees can attend any without prior booking. Delegates may also switch between sessions after they have commenced. Unless otherwise indicated all sessions will be recorded for On-Demand viewing after the ASM.

GENOMIC DATA & IMPLEMENTATION SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 x presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Andrew Mallett
Moderator: Aspasia Pefanis

Daniel MacArthur, Broad Institute of MIT

Cathy Quinlan, The Royal Children’s Hospital

Kushani Jayasinghe, Monash Health

Amali Mallawaarachchi, Royal Prince Alfred Hospital

#1: POPULATION GENOMICS

#2: NEXT GENERATION NEPHROLOGISTS – MAINSTREAMING CLINICAL GENOMICS

#3:GENOMIC SEQUENCING IN THE RENAL CLINIC – ARE WE THERE YET

#4:CLINICAL UTILITY OF WHOLE GENOME SEQUENCING IN NEPHROLOGY

Close Session Details

APSN SPEAKERS CLINICAL SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Muh Geot Wong

Lorraine Kwan, associate consultant in the Department of Medicine, Queen Mary Hospital & Tung Wah Hospital, Hong Kong

Sunita Bavanandan, Consultant Nephrologist and Head of the Department of Nephrology, Hospital Kuala Lumpur, Malaysia

Yusuke Suzuki, Professor of Nephrology, Juntendo School of Medicine, Tokyo, Japan

#1: RECENT ADVANCES IN HAEMODIALYSIS

#2: CLOSING THE GAPS IN PERITONEAL DIALYSIS IN THE SOUTHEAST ASIAN REGION

#3: PATHOGENESIS OF IgAN AND ITS CLINICAL APPLICATION

Close Session Details

ANCA ASSOCIATED VASCULITIS – BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 x 23-minute presentations followed by a 17-minute live Q&A where speakers will answer questions submitted by the audience.

Chair: Guoping Zheng
Moderator: Jennifer Yo

David Jayne, Professor of Clinical Autoimmunity at the University of Cambridge, UK

Kim O’Sullivan, Monash University

Richard Kitching, Monash Univeristy

#1: COMPLEMENT IN AAV PATHOGENESIS – A NEW TARGET FOR THERAPY

2#: NEUTROPHIL ACTIVATION AND MODULATION IN ANCA VASCULITIS

3#: LOSS OF TOLERANCE AND RE-ESTABLISHING TOLERANCE TO ANCA ANTIGENS

Close Session Details

RENAL SUPPORTIVE CARE SYMPOSIUM

View Session Details

Chair: Su Crail, Moderator: Lee Skeat

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Su Crail
Moderator: Lee Skeat

Frank Brennan, Palliative Care and Renal Supportive Care Services, St George Hospital, Kogarah

Kathryn Ducharlet, Nephrology and Renal Supportive Care Services, St Vincent’s Hospital and Eastern Health

Ofra Fried, Palliative Care, Townsville University Hospital, Townsville

#1: SYMPTOM MANAGEMENT IN ADVANCED RENAL DISEASE: TASTE AND ITCH

#2: COMPREHENSIVE CONSERVATIVE CARE: DEFINITIONS, EVIDENCE AND OUTCOMES

#3: CROSS CULTURAL ISSUES IN END OF LIFE CARE FOR PEOPLE WITH ADVANCED RENAL DISEASE

Close Session Details

1235-1330 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall

CONCURRENT SESSIONS
1330-1500

SHAUN SUMMERS CLINICAL TRAINEE AWARD SESSION

View Session Details

This session will comprises of 8 live 5 minute presentations followed by questions from the audience.

Chair: Angela Webster
Moderator: Adam Steinberg

RISK FACTORS FOR DEVELOPMENT OF ACUTE KIDNEY INJURY IN HOSPITALISED ADULTS IN ZIMBABWE
Alexander Gilbert

LOW RISK OF CHRONIC KIDNEY DISEASE ASSOCIATED WITH TENOFOVIR DISOPROXIL FUMERATE-BASED PRE-EXPOSURE PROPHYLAXIS (PREP)
Jack Heron

VANCOMYCIN USE FOR HAEMODIALYSIS PATIENTS- DEVELOPMENT OF A NEW DOSING PROTOCOL
Enya Ho

EXPANDING THE PHENOTYPIC SPECTRUM FOR ALPORT SYNDROME AND DISTINGUISHING PHENOCOPIES IN GENETIC KIDNEY DISEASE
Rebecca Ling

UTILITY OF MYCOPHENOLIC ACID AREA UNDER THE CURVE (MPA-AUC) AFTER MYCOPHENOLATE MOFETIL DOSE REDUCTION (MMF-DR) IN KIDNEY TRANSPLANT RECIPIENTS
Aruni Malaweera

PROLONGED IMMUNOSUPPRESSION DOES NOT IMPROVE RISK OF SENSITISATION OR LIKELIHOOD OF RE-TRANSPLANTATION AFTER KIDNEY TRANSPLANT GRAFT FAILURE
Kylie Martin

PREDICTORS OF HEALTH DETERIORATION OF OLDER ADULTS AFTER 24 MONTHS AND 36 MONTHS OF DIALYSIS THERAPY
Reshma Shettigar

IS THERE A LABELLING EFFECT OF KIDNEY DONOR PROFILE INDEX (KDPI) ON OUR ACCEPTANCE PRACTICE OF DECEASED DONOR KIDNEYS? A SINGLE CENTRE EXPERIENCE
Dhakshayini Tharmaraj

Close Session Details

BASIC SCIENCE AWARD SESSION

View Session Details

This 90 minute session will comprises of 6 live 12 minute presentations followed by questions.

Chair: Jacqueline Phillips
Moderator: David Nikolic-Paterson

NOX5 PROMOTES DIABETIC KIDNEY DISEASE INDEPENDENT OF NOX4 BY ACTIVATING EGR1
Jay Jha

NEUTROPHIL ELASTASE INHIBITION ATTENUATES RENAL INFLAMMATION IN EXPERIMENTAL MYELOPEROXIDASE ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY VASCULITIS
Kim O’Sullivan

SPATIAL TRANSCRIPTOMICS (ST): INTEGRATING MOLECULAR PROFILES WITH HISTOMORPHOLOGY IN MAMMALIAN KIDNEY TISSUE SECTIONS
Arti Raghubar

THROMBOSPONDIN-1 DRIVES CARDIOVASCULAR PATHOLOGY IN CHRONIC KIDNEY DISEASE
Natasha Rogers

TARGETED DELETION OF NADPH OXIDASE NOX4 FROM PROXIMAL TUBULES IS DISPENSABLE FOR DIABETIC KIDNEY DISEASE DEVELOPMENT
Sih Min Tan

β-CATENIN/FOXO PROMOTES EPITHELIAL HEALING AFTER ACUTE KIDNEY INJURY
Guoping Zheng

Close Session Details

MINI ORALS #4 | GLOMERULONEPHRITIS / GENERAL NEPHROLOGY / INTERVENTIONAL NEPHROLOGY / AKI

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Qinghua Cao
Moderator: Evan Owens

WORK DISABILITY AND EMPLOYMENT IN AN AUSTRALIAN COHORT WITH ANCA-ASSOCIATED VASCULITIS
Vanessa Heron

THE IL-7Rα AS A POTENTIAL THERAPEUTIC TARGET IN ANCA-ASSOCIATED GLOMERULONEPHRITIS
Juli Jaw

A RETROSPECTIVE CASE SERIES OF SINGLE, FIXED LOW DOSE RITUXIMAB FOR RELAPSING MINIMAL CHANGE DISEAS
Bree Marsh

EFFECT OF SEVERE CYCLONE ON INCIDENCE OF GLOMERULAR DISEASE IN CENTRAL QUEENSLAND OF AUSTRALIA
Tony Pham

NON-IMMUNOSUPPRESSIVE TREATMENT FOR IGA NEPHROPATHY: AN UPDATED COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS
David Tunnicliffe

LIVE Q&A (GLOMERULONEPHRITIS)

HMG COA REDUCTASE INHIBITORS (STATINS) FOR PEOPLE WITH CHRONIC KIDNEY DISEASE NOT REQUIRING DIALYSIS: A LIVING COCHRANE REVIEW
David Tunnicliffe

THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL
Anushree Tiku

PERCUTANEOUS KIDNEY BIOPSY: CAN WE PREDICT WHICH PATIENTS ARE AT RISK OF BLEEDING COMPLICATIONS?
Aksharaa Anpalahan

KINETIC ESTIMATED GFR (KeGFR) PREDICTS ACUTE KIDNEY INJURY
Daniel Christiadi

ACUTE KIDNEY INJURY (AKI) ELECTRONIC ALERTS AND AKI CARE BUNDLE PROJECT
Sradha Kotwal

LIVE Q&A (GENERAL NEPHROLOGY / INTERVENTIONAL NEPHROLOGY / AKI)

Close Session Details

MINI ORALS #5 | DIABETES / CARDIOVASCULAR / HYPERTENSION / HEALTH SERVICES RESEARCH

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Raelene Pickering
Moderator: Matthew Snelson

INCIDENCE AND PREVALENCE OF MODIFIABLE CARDIOVASCULAR RISK FACTORS ACCORDING TO KIDNEY FUNCTION, GENDER AND GEOGRAPHY
Laura Cuthbertson

KIDNEY IMPLICATIONS OF THE INITIAL ESTIMATED GLOMERULAR FILTRATION RATE RESPONSE TO SODIUM GLUCOSE COTRANSPORTER-2 INHIBITION WITH EMPAGLIFLOZIN; THE ‘ESTIMATED GLOMERULAR FILTRATION RATE DIP’ IN EMPA-REG OUTCOME
Michael D’Emden

BURDEN OF CARDIOVASCULAR DISEASE AND IMPACT ON HOSPITAL ADMISSIONS, COSTS AND DEATH AMONG PRETERMINAL CHRONIC KIDNEY DISEASE PATIENTS
Vishal Diwan

NOX5 AS A POTENTIAL BIOMARKER IN CIRCULATING PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC KIDNEY DISEASE
Tomasz Block

EFFECT OF PHOSPHATE-LOWERING THERAPY ON CARDIAC STRUCTURE AND FUNCTION – A SUB-STUDY OF THE IMPROVE-CKD TRIAL
Nicole Lioufas

BRIEF ANGIOTENSIN CONVERTING ENZYME INHIBITION EARLY IN LIFE DELAYS THE ONSET OF ALBUMINURIA IN SHEEP BORN WITH A SOLITARY FUNCTIONING KIDNEY
Zoe McArdle

WHAT IS THE RELATIONSHIP BETWEEN CARDIOVASCULAR MORBIDITY, DEATH AND ESKF IN PATIENTS WITH DIABETES AND CKD WHO RECEIVE SPECIALIST RENAL CARE?
Ken-Soon Tan

LIVE Q&A (DIABETES / CARDIOVASCULAR / HYPERTENSION)

COLLABORATIVE INDIGENOUS COMMUNITY-BASED RESEARCH: A TOOL-KIT FOR CO-CREATION AND MEANINGFUL COMMUNITY CONSULTATION
Samantha Bateman

HEALTH SERVICE COSTS FOR A PRE-DIALYSIS DIETETIC CLINIC: A RETROSPECTIVE COST ANALYSIS STUDY
Stephanie Notaras

CLINICIAN PERSPECTIVES ON DISPARITIES IN ACCESS TO KIDNEY REPLACEMENT THERAPY IN RURAL AREAS
Nicole Scholes-Robertson

LIVE Q&A (HEALTH SERVICES RESEARCH)

Close Session Details

MINI ORALS #6 | PAEDIATRICS / GENETICS

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Swasti Chaturvedi
Moderator: Prianka Puri

STRATIFYING RISK OF POST TRANSPLANT RECURRENCE AND TRANSPLANT FAILURE IN CHILDREN WITH STEROID RESISTANT NEPHROTIC SYNDROME: A STUDY FROM THE AUSTRALIAN AND NEW ZEALAND PAEDIATRIC NEPHROLOGY ASSOCIATION
Anna Francis

HOMOZYGOUS VARIANTS IN NOS1AP ARE ASSOCIATED WITH STEROID RESISTANT NEPHROTIC SYNDROME IN INFANCY AND MANIFEST PODOCYTE-SPECIFIC APICOBASAL POLARITY DISTURBANCES IN IPSC DERIVED KIDNEY ORGANOIDS
Thomas Forbes

FACTORS ASSOCIATED WITH ALLOGRAFT LOSS IN AUSTRALIAN AND NEW ZEALAND PAEDIATRIC KIDNEY TRANSPLANT PATIENTS
Rowena Lalji

INCIDENCE AND PREDICTORS OF VASCULAR EVENTS FOLLOWING END STAGE KIDNEY DISEASE IN CHILDHOOD
Amelia Le Page

LIVE Q&A (PAEDIATRICS)

MULTIOMICS REVEALS EXTENSIVE MITOCHONDRIAL REMODELLING IN DIABETIC KIDNEY DISEASE
Melinda Couglan

NATIONWIDE DIAGNOSTIC UTILITY OF CLINICAL GENOMICS IN PATIENTS WITH SUSPECTED GENETIC KIDNEY DISEASE
Kushani Jayasinghe

CLINICAL IMPACT OF GENOMIC TESTING IN PATIENTS WITH SUSPECTED MONOGENIC KIDNEY DISEASE
Kushani Jayasinghe

EARLY GENOMIC SEQUENCING INCREASES DIAGNOSTIC YIELD AND IS COST EFFECTIVE IN CHILDREN
Kushani Jayasinghe

ATTITUDES AND PRACTICES OF AUSTRALIAN NEPHROLOGISTS TOWARDS IMPLEMENTATION OF CLINICAL GENOMICS
Kushani Jayasinghe

THE HERITABILITY OF KIDNEY FUNCTION USING AN OLDER AUSTRALIAN TWIN POPULATION
Julia Jefferis

PHARMACOGENOMICS FOR CHRONIC DISEASE MEDICINES IN AN AUSTRALIAN INDIGENOUS POPULATION
Wendy Hoy

LIVE Q&A (GENETICS)

Close Session Details

1500-1505
5 min changeover break

PLENARY #4
Chair: Eddie Tan
HD VASCULAR ACCESS MONITORING/SURVEILLANCE: SINE QUA NON?
1505-1615
Chair: Eddie Tan
Professor Yong-Soo Kim
Professor of Medicine in the Catholic University of Korea College of Medicine in Seoul, Korea

SPEED NETWORKING SOCIAL
1615-1645

DAY TWO CONCLUDES
The Networking Hub remains open for scheduled meetings with sponsors and other attendees. Schedule a meeting through the Networking Hub.

WEDNESDAY

Wednesday, 2nd December 2020

CONCURRENT SESSIONS
0930-1100

GLOMERULAR BASEMENT MEMBRANE & KIDNEY DISEASE – BASIC SCIENCE SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Cathy Quinlan
Moderator: Amali Mallawaarachchi

Rachel Lennon, The University of Manchester, UK

Andrew Mallett, Townsville University Hospital

Ella Wilkins, The Royal Children’s Hospital Renal Genetics Clinic

Judy Savige, Melbourne Health

#1:THE GLOMERULAR MATRISOME IN HEALTH AND DISEASE

#2:GENE AND VARIANT CURATION IN GENETIC KIDNEY DISEASE – PATHWAYS FOR SUCCESS

#3: FAMILY MATTERS: GENETIC COUNSELLING AND TESTING FOR ALPORT SYNDROME

#4: WHAT YOU NEED TO KNOW ABOUT ALPORT SYNDROME

Close Session Details

PCKD SYMPOSIUM

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Jacqueline Philips

Yeoungjee Cho, Centre for Health Services Research The University of Queensland

Ian Smyth, Monash Biomedicine Discovery Institute, Monash University

Gopi Rangan, Westmead Institute for Medical Research, University of Sydney

#1: CORE OUTCOMES FOR TRIALS IN ADPKD: THE SONG_PKD INITIATIVE

#2: IDENTIFICATION OF A NEW REGULATOR OF CYST DEVELOPMENT IN DIFFERENT TYPES OF PKD

#3: DNA DAMAGE RESPONSE PATHWAYS IN POLYSYSTIC KIDNEY DISEASE

Close Session Details

ANZDATA SYMPOSIUM

View Session Details

Chair: Stephen MacDonald & Alan Cass

NEW APPROACHES TO DATA IN TRANSPLANTATION
Georgina Irish

NEW DATA ELEMENTS IN ANZATA
Kylie Hurst

NEW DATA IN ANZDATA – THE CENTRE SURVEY
Erandi Hewawasam

NEW TECHNIQUES FROM ANZDATA – GEOSPATIAL MODELLING
Dominic Keuskamp

NEW PERSPECTIVES IN ANZDATA – CONSUMER ACTIVITIES
Shyamsundar Muth

NEW OUTPUTS FROM ANZDATA KPI REPORTS
Nick Gray

Close Session Details

GREEN NEPHROLOGY SYMPOSIUM

View Session Details

This 90 minute session will consist of 4 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Vincent Lee
Moderator: Katherine Barraclough

Sarah Brown, Purple House

John Knight, The George Institute for Global Health and University of New South Wales

Katherine Barraclough, Royal Melbourne Hospital and University of Melbourne

David Johnson, Princess Alexandra Hospital and University of Queensland

#1: HAEMODIALYSIS PROVISION IN THE CONTEXT OF CLIMATE CHANGE

#2: THE CARBON FOOTPRINT OF PD AND ENVIRONMENTAL WINS FROM THE ELLEN MEDICAL PD SYSTEM

#3: KIDNEY PATIENT CARE IN NATURAL DISASTERS: EMERGENCY PLANNING FOR PATIENTS AND DIALYSIS UNITS

#4: KIDNEY PATIENT CARE IN NATURAL DISASTERS: EMERGENCY PLANNING FOR PATIENTS AND DIALYSIS UNITS

Close Session Details

1100-1200 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall

PLENARY #5 – AWARD PRESENTATIONS
Chair: Suetonia Palmer
1200-1330

TJ Neale – 2020 Award Presentation

Professor Angela Webster
Clinical Epidemiologist, Nephrologist and Transplant Physician, Westmead Hospital

Jacquot Awardee Presentations

Dr Anna Francis
Paediatric nephrologist and clinician researcher with the Queensland Children’s Hospital, and a Jacquot Research Entry Award Entry winner 2017 and 2018, who will speak on the topic of Improving the long-term outcomes for children with CKD

Associate Professor Natasha Rogers
Westmead Hospital, and a Jacquot Research Establishment Award winner in 2016 and 2018

PLENARY #6 – COVID SYMPOSIUM
Chair: Neil Boudville
1330-1500

COVID-19 – AN INSIGHT INTO EXTREME PANDEMIC CONDITIONS

Dr Philip Masson
Consultant Nephrologist, Royal Free Hospital, UK

COVID-19 PANDEMIC AND THE AUSTRALIAN HEALTH PERSPECTIVE

Professor Brendan Murphy
Commonwealth Secretary of Health

1500-1530 EXHIBITION & REFRESHMENT BREAK
Visit with our sponsors in the Exhibition Hall

CONCURRENT SESSIONS
1530-1700

AUSTRALIAN KIDNEY TRIALS NETWORK (AKTN) SYMPOSIUM

View Session Details

This 90 minute session will be broken into three sections.

Chair: Matthew Roberts
Moderator: Carmel Hawley

Acknowledgement of Country

#1: Clinical Trials: From inception to publication and beyond

#2: Adapting to a changing clinical trials landscape

#3: Engaging with the AKTN

Carmel Hawley, Princess Alexandra Hospital, Queensland

Nigel Toussaint, Interim Director of Nephrology, The Royal Melbourne Hospital; Clinical Associate Professor, University of Melbourne

David Johnson, Princess Alexandra Hospital and University of Queensland

Andrea Viecelli, Nephrologist, Princess Alexandra Hospital and University of Queensland

Yeoungjee Cho, Centre for Health Services Research The University of Queensland

#1: HURDLES FOR HOME BASED HAEMODIALYSIS

#2: IMPROVE-CKD

#3: CKD-FIX

#4: WHATS NEW FOR AKTN TRIALS

#5: OPPORTUNITIES AND PATHWAYS FOR ENGAGEMENT

Close Session Details

GENDER EQUALITY IN MEDICINE, NEPHROLOGY & OUR SOCIETY SYMPOSIUM

View Session Details

This 60 minute session will consist of 2 presentations.

Chair: Kate Wyburn

Patrick (Paddy) Mark, Professory of Nephrology and Honorary Consultant Nephrologist at the Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Hospital Glasgow

Lisa Guay-Woodford, McGehee Joyce Professor of Pediatrics at the Children’s National Medical Center (CNMC), Washington

#1: GENDER EQUITY IN NEPHROLOGY – INSIGHTS FROM SCOTLAND!

#2: FOR WOMEN IN NEPHROLOGY: THE POWER OF SISTERHOOD

Close Session Details

SELECTED NEPHROLOGY UPDATES

View Session Details

This 90 minute session will consist of 3 presentations followed by a live Q&A where speakers will answer questions submitted by the audience.

Chair: Sharon Ford

Simon Jiang, John Curtin School of Medical Research and Centre for Personalised Immunology

Peter Hughes, The Royal Melbourne Hospital

Jeremy Chapman, Westmead Hospital, Sydney

#1: PERSONALISED MOLECULAR GENETICS IN LUPUS

#2: ANZKX UPDATES

#3: WHAT HAVE WE LEARNT THIS YEAR

Close Session Details

MINI ORALS #7 | TRANSPLANTATION / EXPERIMENTAL IMMUNOLOGY

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Kim O’Sullivan

PATIENT-REPORTED GASTROINTESTINAL SYMPTOMS AND THE ASSOCIATION WITH QUALITY OF LIFE FOLLOWING KIDNEY TRANSPLANTATION
Samuel Chan

NOTIFIABLE INFECTIONS AMONG KIDNEY TRANSPLANT RECIPIENTS: A DATA-LINKAGE COHORT STUDY, NEW SOUTH WALES, 2000-2015
Nicole De La Mata

ALLOGRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS WHOSE PRIMARY KIDNEY DISEASE WAS ANCA-ASSOCIATED VASCULITIS
Robert Ellis

THE AUSTRALIAN AND NEW ZEALAND LIVING KIDNEY DONOR PROFILE INDEX
Georgina Irish

PRE-TRANSPLANT ORAL GLUCOSE TOLERANCE TESTS IDENTIFY PATIENTS AT RISK OF NEW ONSET DIABETS FOLLOWING KIDNEY TRANSPLANTATION
Julian Singer

MISSED OPPORTUNITIES FOR ORGAN DONATION AMONG DONORS WITH PRIMARY BRAIN TUMOURS (PBT): NEW SOUTH WALES (NSW) COHORT STUDY 2010-2015
Imogen Thomson

PREVALENCE AND CLINICAL ASSOCIATIONS OF SARCOPENIA IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE BEFORE KIDNEY TRANSPLANTATION
Limy Wong

LIPOPOLYSACCHARIDE-STIMULATED MACROPHAGE MCP-1 PRODUCTION DEPENDS UPON SPLEEN TYROSINE KINASE
Xiu Xian Chia

LIVE Q&A

Close Session Details

MINI ORALS #8 | HAEMODIALYSIS

View Session Details

This session will comprise of pre-recorded 5 minute mini oral presentations followed by a group live Q&A sessions where presenters will answer questions from the audience.

Chair: Caroline Chembo
Moderator: Veena Roberts

EXERCISE TRAINING TO IMPROVE PATIENT-IMPORTANT OUTCOMES IN ADULTS UNDERGOING MAINTENANCE DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Amélie Bernier-Jean

PHYSICAL ACTIVITY AND MORTALITY IN ADULTS UNDERGOING HAEMODIALYSIS: A DIET-HD COHORT STUDY
Amélie Bernier-Jean

DIETARY HABITS IN AUSTRALIAN, NEW ZEALAND AND MALAYSIAN PATIENTS WITH END STAGE KIDNEY DISEASE; A PRE-SPECIFIED ANALYSIS OF THE FAVOURED TRIAL PARTICIPANTS
Marguerite Conley

PATIENTS’ EXPERIENCES OF A MOBILE PHONE TEXT MESSAGE INTERVENTION TO IMPROVE DIETARY BEHAVIOURS IN HAEMODIALYSIS (KIDNEYTEXT)
Jessica Dawson

COST-EFFECTIVENESS OF A MOBILE PHONE TEXT MESSAGING INTERVENTION (KIDNEYTEXT) TO IMPROVE DIETARY BEHAVIOURS IN PEOPLE RECEIVING HAEMODIALYSIS
Jessica Dawson

WELLBEING INTERVENTION FOR CHRONIC KIDNEY DISEASE: THE WICKD TRIAL
Jaquelyne Hughes

LIVE Q&A

THE EFFICIENCY OF A NOVEL ASYMMETRICAL CELLULOSE TRIACETATE DIALYSIS MEMBRANE COMPARED TO A STANDARD HIGH-FLUX DIALYSIS MEMBRANE; A PILOT STUDY
Kamya Kameshwar

SEX DISPARITY IN CAUSE-SPECIFIC MORTALITY IN PATIENTS WITH KIDNEY FAILURE
Kimberley Sonya Minas

FEASIBILITY AND ACCEPTABILITY OF ELECTRONIC PATIENT REPORTED OUTCOME MEASURES (E-PROMS) DATA CAPTURE IN THE SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) PILOT: PERSPECTIVES OF NEPHROLOGISTS, NURSES AND PATIENTS
Rachael Morton

FEASIBILITY AND ACCEPTABILITY OF SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) FOR ADULTS ON HAEMODIALYSIS: A PILOT ANZDATA REGISTRY-BASED CLUSTER RANDOMISED TRIAL
Rachael Morton